Hyperfine (HYPR) Gains from Investment Securities (2020 - 2025)
Hyperfine (HYPR) reported Gains from Investment Securities of -$705000.0 for Q4 2025, down 116.92% on a YoY basis from $4.2 million in Q4 2024, and down 130.61% quarter-over-quarter from $2.3 million in Q3 2025.
Hyperfine (HYPR) Gains from Investment Securities (2020 - 2025) Analysis & Trends
Hyperfine has reported Gains from Investment Securities for 6 years, with the latest figure at -$705000.0 in Q4 2025.
- For the quarter ending Q4 2025, Gains from Investment Securities fell 116.92% year-over-year to -$705000.0; the trailing twelve-month figure through Dec 2025 stood at -$345000.0 (down 505.26% YoY), and the FY2025 full-year result was $15.5 million, up 3820.25% from the prior year.
- Gains from Investment Securities for Q4 2025 stood at -$705000.0, down from $2.3 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $18.5 million in Q2 2024, with the low at -$1.6 million in Q1 2025.
- Historically, Gains from Investment Securities has averaged $1.7 million across 5 years, with a median of $644000.0 in 2021.
- Annual changes were most pronounced in 2022 — Gains from Investment Securities soared 60352.76% — and 2024, when it tumbled 221.27%.
- Hyperfine's Gains from Investment Securities stood at $587000.0 in 2021, then advanced by 18.23% to $694000.0 in 2022, then sank by 61.38% to $268000.0 in 2023, then plunged by 221.27% to -$325000.0 in 2024, then tumbled by 116.92% to -$705000.0 in 2025.
- The last three Gains from Investment Securities figures came in at -$705000.0 (Q4 2025), $2.3 million (Q3 2025), and $2.5 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Hyperfine | 133.84 Mn | 92.56 Mn | 1.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -705,000.00 |
| Dec 31, 2025 | -705,000.00 |
| Sep 30, 2025 | 2.30 Mn |
| Sep 30, 2025 | 2.30 Mn |
| Jun 30, 2025 | 2.53 Mn |
| Jun 30, 2025 | 2.53 Mn |
| Mar 31, 2025 | -1.62 Mn |
| Mar 31, 2025 | -1.62 Mn |
| Dec 31, 2024 | -325,000.00 |
| Dec 31, 2024 | -325,000.00 |
| Jun 30, 2024 | 18.50 Mn |
| Jun 30, 2024 | 18.50 Mn |
| Dec 31, 2023 | 268,000.00 |
| Dec 31, 2023 | 268,000.00 |
| Sep 30, 2023 | 879,190.00 |
| Sep 30, 2023 | 879,190.00 |
| Jun 30, 2023 | 798,260.00 |
| Jun 30, 2023 | 798,260.00 |
| Mar 31, 2023 | 1.00 Mn |
| Mar 31, 2023 | 1.00 Mn |